Association Between Angiotensin-Converting Enzyme and Alzheimer Disease
Author(s) -
Lindsay A. Farrer,
T. Sherbatich,
S.A. Keryanov,
Г. И. Коровайцева,
Ekaterina Rogaeva,
Svetlana Petruk,
Premkumar Segaran,
Y Moliaka,
YouQiang Song,
York Pei,
Christine Sato,
Selezneva Nd,
Svetlana Voskresenskaya,
В. Е. Голимбет,
Sandro Sorbi,
Ranjan Duara,
Gavrilova Si,
Peter St GeorgeHyslop,
Е. И. Рогаев
Publication year - 2000
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.57.2.210
Subject(s) - odds ratio , apolipoprotein e , angiotensin converting enzyme , medicine , genotype , confidence interval , alzheimer's disease , allele , risk factor , endocrinology , disease , gastroenterology , biology , genetics , gene , blood pressure
Angiotensin-converting enzyme has been reported to show altered activity in patients with neurologic diseases. An insertion-deletion polymorphism in ACE has recently been linked to heart disease, cerebrovascular disease, and AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom